ArticleInternational journal of molecular sciences2026
Inferring circRNA-Disease Associations via Sparse Topological Representation Learning and Dual-View Decoding.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CSDPCDA: A miRNA-Mediated Cross-Semantic Regulatory Network Framework for Predicting circRNA-Disease Associations.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Circular RNAs (circRNAs) are key regulators in the onset and progression of complex diseases, offering promise as diagnostic and prognostic biomarkers. However, most putative circRNA-disease associations remain experimentally unverified, largely due to the cost and time demands of wet-lab approaches. To bridge this gap, we present STRCDA (Sparse Topological Representation learning for CircRNA-Disease Associations). The pipeline first constructs fused similarity profiles for circRNAs and diseases by integrating diverse biological attributes. These initial matrices are then refined via random walk with restart to capture local features. Subsequently, a sparse-constrained dual-branch graph autoencoder extracts holistic topological embeddings from the refined local features and the known interaction network. Finally, an XGBoost classifier scores potential circRNA-disease pairs. On the CircR2Disease dataset, STRCDA achieves an AUC of 0.9771 and an AUPR of 0.9826 under five-fold cross-validation. Notably, 18 of the top 20 predicted associations were confirmed by independent experimental evidence, highlighting STRCDA's efficacy as a robust tool for uncovering circRNA function in disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.